151 related articles for article (PubMed ID: 29777922)
1. PFOA and ulcerative colitis.
Steenland K; Kugathasan S; Barr DB
Environ Res; 2018 Aug; 165():317-321. PubMed ID: 29777922
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
3. Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012.
Herrick RL; Buckholz J; Biro FM; Calafat AM; Ye X; Xie C; Pinney SM
Environ Pollut; 2017 Sep; 228():50-60. PubMed ID: 28505513
[TBL] [Abstract][Full Text] [Related]
4. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
[TBL] [Abstract][Full Text] [Related]
6. PFOA and PFOS serum levels and miscarriage risk.
Darrow LA; Howards PP; Winquist A; Steenland K
Epidemiology; 2014 Jul; 25(4):505-12. PubMed ID: 24807698
[TBL] [Abstract][Full Text] [Related]
7. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study.
Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF
Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
9. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
10. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
[TBL] [Abstract][Full Text] [Related]
11. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.
Shivashankar R; Tremaine WJ; Harmsen WS; Loftus EV
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):857-863. PubMed ID: 27856364
[TBL] [Abstract][Full Text] [Related]
13. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
14. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498
[TBL] [Abstract][Full Text] [Related]
15. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
[TBL] [Abstract][Full Text] [Related]
16. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
17. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study.
Melmed GY; Elashoff R; Chen GC; Nastaskin I; Papadakis KA; Vasiliauskas EA; Liu W; Landers C; Ippoliti AF; Targan SR
Clin Gastroenterol Hepatol; 2007 May; 5(5):602-8; quiz 525. PubMed ID: 17478347
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
[TBL] [Abstract][Full Text] [Related]
19. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
20. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study.
Rubio CA; Befrits R
Dis Colon Rectum; 1997 Sep; 40(9):1072-8. PubMed ID: 9293938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]